Skip to main content
Erschienen in: Breast Cancer 6/2016

11.12.2015 | Case Report

A very rare case of breast cancer in a female-to-male transsexual

verfasst von: Yuko Katayama, Takayuki Motoki, Satoko Watanabe, Saiga Miho, Yoshihiro Kimata, Junji Matsuoka, Hiroyoshi Doihara, Yuzaburo Nanba

Erschienen in: Breast Cancer | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

The incidence of breast cancer in female-to-male (FTM) transsexuals who received mastectomy and sex reassignment surgery is very rare. In fact, there is only one previous medical report of such a case. We experienced a case of an FTM transsexual who developed breast cancer 12 years after mastectomy and hysterectomy with bilateral salpingo-oophorectomy. Because he had been continuously receiving testosterone during the last 15 years and because histopathological examination revealed positive estrogen receptor and androgen receptor expression, we suggest that exogenous testosterone may have initiated the development of breast cancer via two distinct pathways. We describe the clinical course and condition of the patient and recommend that medical personnel consider the possibility of hormone-related cancer in FTM transsexuals receiving cross-sex hormones.
Literatur
1.
Zurück zum Zitat Gooren L, Bowers M, Lips P, Konings IR. Five new cases of breast cancer in transsexual persons. Andrologia. 2015; 22. doi:10.1111/and.12399. Gooren L, Bowers M, Lips P, Konings IR. Five new cases of breast cancer in transsexual persons. Andrologia. 2015; 22. doi:10.​1111/​and.​12399.
2.
Zurück zum Zitat Burcombe RJ, Makris A, Pittam M, Finer N. Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast. 2003;12:290–3.CrossRefPubMed Burcombe RJ, Makris A, Pittam M, Finer N. Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast. 2003;12:290–3.CrossRefPubMed
3.
Zurück zum Zitat Shao T, Grossbard ML, Klein P. Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer. 2011;11:417–9.CrossRefPubMed Shao T, Grossbard ML, Klein P. Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer. 2011;11:417–9.CrossRefPubMed
4.
Zurück zum Zitat Dejan V Nikolic, Miroslav L Djordjevic, Miroslav Granic, Aleksandra T Nikolic, Violeta V Stanimirovic, Darko Zdravkovic, et al. Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy. World J Sung Oncol. 2012; 28. doi:10.1186/1477-7819-10-280. Dejan V Nikolic, Miroslav L Djordjevic, Miroslav Granic, Aleksandra T Nikolic, Violeta V Stanimirovic, Darko Zdravkovic, et al. Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy. World J Sung Oncol. 2012; 28. doi:10.​1186/​1477-7819-10-280.
5.
Zurück zum Zitat Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006;354:270–82.CrossRefPubMed Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006;354:270–82.CrossRefPubMed
6.
Zurück zum Zitat Secreto G, Zumoff B. Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer. Anticancer Res. 2012;32:3223–8.PubMed Secreto G, Zumoff B. Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer. Anticancer Res. 2012;32:3223–8.PubMed
7.
Zurück zum Zitat Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, et al. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer. 2003;98:703–11.CrossRefPubMed Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, et al. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer. 2003;98:703–11.CrossRefPubMed
8.
Zurück zum Zitat Nahleh Z. Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory. Future Oncol. 2008;4:15–21.CrossRefPubMed Nahleh Z. Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory. Future Oncol. 2008;4:15–21.CrossRefPubMed
9.
Zurück zum Zitat Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH, et al. Expression of androgen receptors in primary breast cancer. Ann Oncol. 2010;21:488–92.CrossRefPubMed Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH, et al. Expression of androgen receptors in primary breast cancer. Ann Oncol. 2010;21:488–92.CrossRefPubMed
10.
Zurück zum Zitat Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med. 2002;15:678–87.CrossRef Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med. 2002;15:678–87.CrossRef
11.
Zurück zum Zitat James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjonneland A, et al. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study. Cancer Prev Res. 2011;4:1626–35.CrossRef James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjonneland A, et al. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study. Cancer Prev Res. 2011;4:1626–35.CrossRef
12.
Zurück zum Zitat Nicolas Diaz-Chico B, German Rodriguez F, Gonazalez A, Ramirez R, Bilbao C, Cabrera de Lekon A, et al. Androgens and androgen receptors in breast cancer. J Steroid Bichem Mol Biol. 2007;105:1–15.CrossRef Nicolas Diaz-Chico B, German Rodriguez F, Gonazalez A, Ramirez R, Bilbao C, Cabrera de Lekon A, et al. Androgens and androgen receptors in breast cancer. J Steroid Bichem Mol Biol. 2007;105:1–15.CrossRef
13.
Zurück zum Zitat Adly L, Hill D, Sherman ME, Sturgeon SR, Fears T, Mies C, et al. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women. Int J Cancer. 2006;119:2702–7.CrossRef Adly L, Hill D, Sherman ME, Sturgeon SR, Fears T, Mies C, et al. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women. Int J Cancer. 2006;119:2702–7.CrossRef
14.
Zurück zum Zitat Danforth KN, Eliassen AH, Tworoger SS, Missmer SA, Barbieri PL, Rosner BA, et al. The association of plasma androgen levels with breast, ovarian and endometrial cancer risk among postmenopausal women. Int J Cancer. 2010;126:199–207.CrossRefPubMedPubMedCentral Danforth KN, Eliassen AH, Tworoger SS, Missmer SA, Barbieri PL, Rosner BA, et al. The association of plasma androgen levels with breast, ovarian and endometrial cancer risk among postmenopausal women. Int J Cancer. 2010;126:199–207.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Wei B, Ding T, Xing Y, Wei W, Tian Z, Tang F, et al. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer. 2010;116:4463–73.CrossRefPubMed Wei B, Ding T, Xing Y, Wei W, Tian Z, Tang F, et al. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer. 2010;116:4463–73.CrossRefPubMed
Metadaten
Titel
A very rare case of breast cancer in a female-to-male transsexual
verfasst von
Yuko Katayama
Takayuki Motoki
Satoko Watanabe
Saiga Miho
Yoshihiro Kimata
Junji Matsuoka
Hiroyoshi Doihara
Yuzaburo Nanba
Publikationsdatum
11.12.2015
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 6/2016
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-015-0661-4

Weitere Artikel der Ausgabe 6/2016

Breast Cancer 6/2016 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.